Depletion of the m6A demethylases FTO and ALKBH5 impairs growth and metastatic capacity through EMT phenotype change in clear cell renal cell carcinoma

被引:0
|
作者
Hu, Wei [1 ,2 ,3 ]
Klumper, Niklas [1 ]
Schmidt, Doris [1 ]
Ritter, Manuel [1 ]
Ellinger, Jorg [1 ]
Hauser, Stefan [1 ,4 ]
机构
[1] Univ Hosp Bonn, Dept Urol, Bonn, Germany
[2] Wuhan Univ, Renmin Hosp, Dept Urol, Wuhan, Hubei, Peoples R China
[3] Wuhan Univ, Renmin Hosp, Dept Urol, Jiefang Rd 238, Wuhan 430060, Hubei, Peoples R China
[4] Univ klinikum Bonn, Klinik & Poliklin Urol & Kinderurol, Bonn, Germany
来源
关键词
m6A-erasers; clear cell renal cell carcinoma (ccRCC); epithelial-mesenchymal transition (EMT); FTO; ALKBH5; DNA METHYLATION ANALYSIS; RNA; EXPRESSION; ERASERS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: N6-methyladenosine (m6A) is one of the most common RNA modifications in eukaryotes and has effects on RNA structure and stability. Recent studies have shown that m6A methylation is involved in human carcinogenesis. In the present study, we investigated the effects of m6A demethylases FTO and ALKBH5 on renal cell carcinoma (RCC) cell lines. Methods: The epithelial-mesenchymal in vitro knockdowns of FTO and ALKBH5 induced by antisense oligonucleotides (LNA-GapmeR system) were established in RCC cell lines. Their effects on migration and proliferation were investigated subsequently. The influence of FTO and ALKBH5 knockdown on key epithelialmesenchymal transition (EMT) genes was analyzed. Results: Inactivation of FTO and ALKBH5 resulted in decreased proliferation and motility in all cell lines examined (ACHN, Caki-1, 769-P). Vimentin (VIM) was downregulated after the knockdown of FTO and ALKBH5, indicating an EMT switch. Conclusions: Knockdown of the m6A erasers FTO and ALKBH5 inhibits the malignant potential in the cell cultures studied by means of an EMT switch.
引用
收藏
页码:1744 / +
页数:14
相关论文
共 50 条
  • [41] m6A demethylase ALKBH5 promote tumor growth through IGF2BPs' recognition of m6A modified CDKN1A in non-small lung cancer.
    Tsuchiya, Kazuo
    Yoshimura, Katsuhiro
    Inoue, Yusuke
    Iwashita, Yuji
    Ohta, Tsutomu
    Yamada, Hidetaka
    Watanabe, Hirofumi
    Tao, Hong
    Kawase, Akikazu
    Tanahashi, Masayuki
    Ogawa, Hiroshi
    Funai, Kazuhito
    Shinmura, Kazuya
    Suda, Takafumi
    Sugimura, Haruhiko
    CANCER RESEARCH, 2021, 81 (13)
  • [42] Prognostic and tumor microenvironmental feature of clear cell renal cell carcinoma revealed by m6A and lactylation modification-related genes
    Yang, Lin
    Wang, Xiaoyu
    Liu, Jiahao
    Liu, Xiaoqiang
    Li, Sheng
    Zheng, Fuchun
    Dong, Qianxi
    Xu, Songhui
    Xiong, Jing
    Fu, Bin
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [43] MicroRNA-133a-5p inhibiting metastatic capacity of renal clear cell carcinoma through regulating MON2
    Li, P.
    Wu, Q.
    Yang, X-R
    Sun, T.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (11) : 5988 - 5995
  • [44] A Novel m6A Gene Signature Associated With Regulatory Immune Function for Prognosis Prediction in Clear-Cell Renal Cell Carcinoma
    Chen, Siteng
    Zhang, Ning
    Zhang, Encheng
    Wang, Tao
    Jiang, Liren
    Wang, Xiang
    Zheng, Junhua
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 8
  • [45] m6A RNA methylation regulators correlate with malignant progression and have potential predictive values in clear cell renal cell carcinoma
    Zhang, Qi-jie
    Luan, Jiao-chen
    Song, Le-bin
    Cong, Rong
    Ji, Chen-jian
    Zhou, Xiang
    Xia, Jia-dong
    Song, Ning-hong
    EXPERIMENTAL CELL RESEARCH, 2020, 392 (01)
  • [46] Construction and validation of an m6A RNA methylation regulator prognostic model for early-stage clear cell renal cell carcinoma
    Wang, Zhan
    Zhang, Mingxin
    Seery, Samuel
    Zheng, Guoyang
    Wang, Wenda
    Zhao, Yang
    Wang, Xu
    Zhang, Yushi
    ONCOLOGY LETTERS, 2022, 24 (02)
  • [47] Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma - a retrospective study using TCGA dataoase
    Zhou, Jingcheng
    Wang, Jiangyi
    Hong, Baoan
    Ma, Kaifang
    Xie, Haibiao
    Li, Lei
    Zhang, Kenan
    Zhou, Bowen
    Cai, Lin
    Gong, Kan
    AGING-US, 2019, 11 (06): : 1633 - 1647
  • [48] ALKBH5 Modulates Hematopoietic Stem and Progenitor Cell Energy Metabolism through m 6a Modification-Mediated RNA Stability
    Gao, Yimeng
    Zimmer, Joshua T.
    Vasic, Radovan
    Liu, Chengyang
    Gbyli, Rana
    Zheng, Shu-Jian
    Patel, Amisha
    Liu, Wei
    Nelakanti, Raman
    Song, Yuanbin
    Biancon, Giulia
    Xiao, Andrew
    Slavoff, Sarah
    Simon, Matthew D.
    Flavell, Richard
    Tebaldi, Toma
    Li, Hua-Bing
    Halene, Stephanie
    BLOOD, 2021, 138
  • [49] m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program
    Zhang, Sicong
    Zhao, Boxuan Simen
    Zhou, Aidong
    Lin, Kangyu
    Zheng, Shaoping
    Lu, Zhike
    Chen, Yaohui
    Sulman, Erik P.
    Xie, Keping
    Bogler, Oliver
    Majumder, Sadhan
    He, Chuan
    Huang, Suyun
    CANCER CELL, 2017, 31 (04) : 591 - +
  • [50] Bioinformatics analysis of markers based on m6A related to prognosis combined with immune invasion of renal clear cell carcinoma
    Liu, Lian
    Zhuang, Meng
    Tu, Xin-Hua
    Li, Cheng-Cheng
    Liu, Hong-Hui
    Wang, Jing
    CELL BIOLOGY INTERNATIONAL, 2023, 47 (01) : 260 - 272